Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50
Conditions: COVID-19; SARS-CoV-2 Interventions: Drug: Ivermectin; Drug: Placebo Sponsor: Insud Pharma Terminated
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials